| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Bernard Coulie
Also a director
President and CEO
Title from the Form 4 dated Apr 17, 2026
|
60 | Not stated | $5,462,901 | |
|
Keith Cummings
Chief Financial Officer
|
49 |
Since 2018
8 years
|
$2,397,337 | |
|
Minnie Kuo
Chief Operating Officer
|
45 |
Since 2025
1 year
|
$1,542,854 | |
|
Lily Cheung
Chief Human Resources Officer
|
53 |
Since 2023
3 years
|
Not reported | |
|
David Raben
Chief Medical Officer
Title from the Form 4 dated Oct 1, 2026
|
Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 22, 2026 · updated by the 8-K of Jul 13, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Hoyoung Huh
Board chair
|
56 |
2017
9 years
|
Independent |
Compensation Committee
|
None stated | Not stated | |
|
Bernard Coulie
CEO
|
60 |
2016
10 years
|
Not independent | None stated | Septerna, Inc. | Paid as CEO | |
|
Gayle Crowell
|
75 |
2019
7 years
|
Independent |
Audit Committee
|
None stated | $95,100 | |
|
Steve Krognes
|
57 |
2024
2 years
|
Independent | None stated | Denali Therapeutics | $95,100 | |
|
Darren Cline
|
61 |
2023
3 years
|
Independent | None stated | Pyxis Oncology, Inc. | $90,100 | |
|
John Curnutte
|
74 |
2017
9 years
|
Independent |
Research and Development Committee
|
None stated | Not stated | |
|
Thomas McCourt
|
68 |
2023
3 years
|
Independent |
Compensation Committee
Research and Development Committee
|
None stated | $90,100 | |
|
Robert Iannone
Joined Jul 9, 2026
|
- | - | Independent |
Research and Development Committee
|
- | - | |
|
Suzanne Bruhn
Leaving at the meeting
|
Not stated | Not stated | Independent |
Compensation Committee
Nominating and Corporate Governance Committee
|
None stated | Not stated | |
|
David Pyott
Leaving at the meeting
|
Not stated | Not stated | Independent |
Audit Committee
Nominating and Corporate Governance Committee
|
None stated | $90,100 | |
|
Katharine Knobil
Leaving at the meeting
|
Not stated | Not stated | Independent |
Nominating and Corporate Governance Committee
|
None stated | $95,100 |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 22, 2026 states there were none.
Read it in the proxyLoading...